Baseline computed tomography screening and blood microRNA predict lung cancer risk and define adequate intervals in the BioMILD trial
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference37 articles.
1. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018;Ferlay;Eur J Cancer,2018
2. Cancer statistics, 2021;Siegel;CA Cancer J Clin,2021
3. Reduced lung-cancer mortality with low-dose computed tomographic screening;N Engl J Med,2011
4. Reduced lung-cancer mortality with volume CT screening in a randomized trial;de Koning;N Engl J Med,2020
5. Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy;Pastorino;Ann Oncol,2019
Cited by 43 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Study rationale and design of the PEOPLHE trial;La radiologia medica;2024-02-06
2. miR-Blood – a small RNA atlas of human blood components;Scientific Data;2024-02-02
3. Consistency of automated coronary calcium score and extent of emphysema with different CT scanners and radiation dose protocols in lung cancer screening;2024-01-11
4. Emerging Strategies in Lung Cancer Screening: Blood and Beyond;Clinical Chemistry;2024-01
5. Current and Future Perspectives on Computed Tomography Screening for Lung Cancer: A Roadmap From 2023 to 2027 From the International Association for the Study of Lung Cancer;Journal of Thoracic Oncology;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3